KLI

근육경직의 약물치료

Metadata Downloads
Alternative Title
Pharmacological management of muscle spasticity
Abstract
Background: Muscle spasticity is a neurologic disorder, which is considered one of the positive signs of upper motor neuron diseases. Spasticity is common after brain or spinal cord injury. Since spasticity results in tendon retraction, muscle weakness, pain, ankylosis, and disability in activities of daily living, treatment is warranted.

Current Concepts: Spasticity is usually assessed using the Modified Ashworth Scale or Modified Tardieu Scale. It is treated with various methods, including physical therapy, occupational therapy, orthosis, medication, and surgery. Pharmacological management should be selected according to the location and severity of the symptom and includes oral medications, chemical nerve block, and intrathecal baclofen pump insertion. Oral medications include baclofen, benzodiazepine, dantrolene, and tizanidine. Chemoneurolysis of spasticity is done with
botulinum toxin or a mixture of phenol and alcohol.

Discussion and Conclusion: Since muscle spasticity affects motor function and activities of daily living, understanding of this symptom and choosing an optimal treatment are necessary. Pharmacologic treatments should be administered with caution especially with the side effects. Optimal treatment of spasticity will bring
the best neurological outcome for the patients.
Author(s)
고은재김대열
Issued Date
2022
Type
Article
Keyword
Muscle spasticityDrug therapyMotor activityActivities of daily living
DOI
10.5124/jkma.2022.65.2.117
URI
https://oak.ulsan.ac.kr/handle/2021.oak/15013
Publisher
대한의사협회지
Language
한국어
ISSN
1975-8456
Citation Volume
65
Citation Number
2
Citation Start Page
117
Citation End Page
122
Appears in Collections:
Medicine > Nursing
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.